A compound having a structure of Formula I,
A compound having a structure of Formula I,
A compound having a structure of Formula I,
is provided. In Formula I, moiety A is a monocyclic ring or a polycyclic fused ring system; M is Pt or Pd; each of X1 to X18, T1 to T4, Z1, and Z2 is C or N; C* is a carbene carbon; each of A1 and A2 is a linking atom; Y1 is a linking atom; each of L1 and L2 is a direct bond or a linking atom; each of K1 to K4 is a direct bond or a linking atom; and each R is hydrogen or a General Substituent defined herein. Compositions, OLEDs, and consumer products containing the compound are also provided.
Provided are organic compounds comprising at least two fused 6-membered rings wherein a same boron atom is part of both fused 6-membered rings and wherein at least one of the two fused 6-membered rings further contains a nitrogen atom. Also provided are formulations comprising these organic compounds. Further provided are organic light emitting devices (OLEDs) as well as related consumer products that utilize these organic compounds.
A compound of formula Ir(LA)x(LB)y(LC)z is provided where each of x and y is independently 1 or 2; z is 0 or 1; and x+y+z=3. In the compound, first ligand LA includes a structure of Formula I,
A compound of formula Ir(LA)x(LB)y(LC)z is provided where each of x and y is independently 1 or 2; z is 0 or 1; and x+y+z=3. In the compound, first ligand LA includes a structure of Formula I,
A compound of formula Ir(LA)x(LB)y(LC)z is provided where each of x and y is independently 1 or 2; z is 0 or 1; and x+y+z=3. In the compound, first ligand LA includes a structure of Formula I,
ligand LB includes a structure of Formula II,
A compound of formula Ir(LA)x(LB)y(LC)z is provided where each of x and y is independently 1 or 2; z is 0 or 1; and x+y+z=3. In the compound, first ligand LA includes a structure of Formula I,
ligand LB includes a structure of Formula II,
A compound of formula Ir(LA)x(LB)y(LC)z is provided where each of x and y is independently 1 or 2; z is 0 or 1; and x+y+z=3. In the compound, first ligand LA includes a structure of Formula I,
ligand LB includes a structure of Formula II,
ligand LC is a bidentate ligand; moiety A is a monocyclic ring or a polycyclic fused ring system; each of X1 to X14 is C or N; Y is a linking group; each RA, RB, RC, RD, RE, RY, and RY′ is hydrogen or a General Substituent defined herein; each of R1, R2, and R3 is an alkyl or cycloalkyl, that can be partially or fully deuterated or fluorinated; and RD1 is a cycloalkyl group or an alkyl group comprising at least two C atoms. Formulations, OLEDs, and consumer products containing the compound are also provided.
A compound having the formula Ir(LA)x(LB)y(LC)z is disclosed wherein ligand LA has a structure of Formula I,
A compound having the formula Ir(LA)x(LB)y(LC)z is disclosed wherein ligand LA has a structure of Formula I,
A compound having the formula Ir(LA)x(LB)y(LC)z is disclosed wherein ligand LA has a structure of Formula I,
ligand LB has a structure of Formula II,
A compound having the formula Ir(LA)x(LB)y(LC)z is disclosed wherein ligand LA has a structure of Formula I,
ligand LB has a structure of Formula II,
A compound having the formula Ir(LA)x(LB)y(LC)z is disclosed wherein ligand LA has a structure of Formula I,
ligand LB has a structure of Formula II,
and ligand LC is a bidentate ligand. R1, R2, R3, R4, RD, and RE do not include an electron-withdrawing group; if R1 has an alkyl group with four and more carbon atoms, then RA1 is not neopentyl; and R1 is not a trialkylsilyl or trilalkylgermyl group. Further, at least one is true: at least one RB or RC comprises heteroaryl, wherein the heteroaryl does not comprise the structure,
A compound having the formula Ir(LA)x(LB)y(LC)z is disclosed wherein ligand LA has a structure of Formula I,
ligand LB has a structure of Formula II,
and ligand LC is a bidentate ligand. R1, R2, R3, R4, RD, and RE do not include an electron-withdrawing group; if R1 has an alkyl group with four and more carbon atoms, then RA1 is not neopentyl; and R1 is not a trialkylsilyl or trilalkylgermyl group. Further, at least one is true: at least one RB or RC comprises heteroaryl, wherein the heteroaryl does not comprise the structure,
A compound having the formula Ir(LA)x(LB)y(LC)z is disclosed wherein ligand LA has a structure of Formula I,
ligand LB has a structure of Formula II,
and ligand LC is a bidentate ligand. R1, R2, R3, R4, RD, and RE do not include an electron-withdrawing group; if R1 has an alkyl group with four and more carbon atoms, then RA1 is not neopentyl; and R1 is not a trialkylsilyl or trilalkylgermyl group. Further, at least one is true: at least one RB or RC comprises heteroaryl, wherein the heteroaryl does not comprise the structure,
two RB or RC groups are joined to form a fused carbocyclic or heterocyclic ring; or X8 is N, or C with RB attached thereto being D, or CD3, and RA1 is a secondary or tertiary alkyl, cycloalkyl, heteroaryl, or ortho-substituted aryl. Compositions, OLEDs, and consumer products containing the compound are also provided.
C07D 401/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
H10K 85/60 - Organic compounds having low molecular weight
A compound including a first ligand LA of Formula I,
A compound including a first ligand LA of Formula I,
A compound including a first ligand LA of Formula I,
is described. In Formula I, each of X1 to X9 is independently C or N; one of Z1 and Z2 is C and the other is N; each of K1 and K2 is independently a direct bond, O, or S; at least one of K1 and K2 is a direct bond; at least one RB is not hydrogen; R3 is selected from alkyl, heteroalkyl, cycloalkyl, and heterocycloalkyl; LA is coordinated to a metal M; at least one of the following is true: (i) at least one RB comprises a 5- or 6-membered, (ii) two adjacent RB are joined to form a fused 5- or 6-membered ring, or (iii) RB comprises a carbocyclic or heterocyclic ring substituted with at least one electron withdrawing group. Devices, consumer products, and formulations including the compound are also described.
Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.
A compound having a structure of Formula I,
A compound having a structure of Formula I,
A compound having a structure of Formula I,
is provided. In Formula I, M is Pd or Pt; each of moiety A and, when present moieties B and C, is independently a monocyclic ring or a polycyclic fused ring system; X5′ and X4′ are optionally joined to form moiety B, which is optionally substituted by one or more RB; X3′ and X2′ are optionally joined to form moiety C, which is optionally substituted by one or more RC; L1 is present or absent; the dashed line - - - - - between X2 and X7 is a direct bond or no bond; and each substituent is independently hydrogen or a General Substituent defined herein. Compositions, OLEDs, and consumer products containing the compound are also provided.
A compound having a first ligand LA having the structure of Formula I
A compound having a first ligand LA having the structure of Formula I
A compound having a first ligand LA having the structure of Formula I
is provided. Moiety AA is a monocyclic ring or a polycyclic fused ring system; moiety CC is a monocyclic ring. At least one RBB or RCC comprises a silyl group or a germyl group. At least one of the following is true: two RBB substituents are joined or fused to form a moiety BB′ that is fused to ring BB, wherein moiety BB′ can be further fused or substituted by RBB′; or two RCC substituents are joined or fused to form a moiety CC′ that is fused to moiety CC, wherein moiety CC′ can be further fused or substituted by RCC′. Compositions, OLEDs, and consumer products containing the compound are also provided.
A compound of Formula Ir(LA)x(LB)y(LC)z is provided where LB and LC are each independently a bidentate ligand; first ligand LA comprises a structure of Formula I,
A compound of Formula Ir(LA)x(LB)y(LC)z is provided where LB and LC are each independently a bidentate ligand; first ligand LA comprises a structure of Formula I,
A compound of Formula Ir(LA)x(LB)y(LC)z is provided where LB and LC are each independently a bidentate ligand; first ligand LA comprises a structure of Formula I,
and at least one RC substituent is R*, which comprises a structure of Formula II,
A compound of Formula Ir(LA)x(LB)y(LC)z is provided where LB and LC are each independently a bidentate ligand; first ligand LA comprises a structure of Formula I,
and at least one RC substituent is R*, which comprises a structure of Formula II,
A compound of Formula Ir(LA)x(LB)y(LC)z is provided where LB and LC are each independently a bidentate ligand; first ligand LA comprises a structure of Formula I,
and at least one RC substituent is R*, which comprises a structure of Formula II,
In the Formula Ir(LA)x(LB)y(LC)z, each of moiety A, moiety C, and, when present, moiety D is a monocyclic ring or a polycyclic fused ring system; each of Z1, Z2, and X1 to X4 is C or N; K is a single bond or a linker; Y is a linking group; each of Y1 and Y2 is selected from O, S, Se, B, or N; Z is C, B, N, O, Si, or P; if Z is C, then Y1 and Y2 are N; L is a direct bond or an organic linker; and each substituent is hydrogen or a General Substituent defined herein. Compositions, OLEDs, and consumer products containing the compound are also provided.
Novel compounds useful as hosts in OLEDs having Formula I
Novel compounds useful as hosts in OLEDs having Formula I
Novel compounds useful as hosts in OLEDs having Formula I
is disclosed.
C07D 519/00 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
H10K 50/11 - OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
The present invention relates to OLED devices and stacks for OLED devices that include a symmetric emissive-layer architecture. In one embodiment, the present invention relates to an emissive stack having three layers, wherein the top and bottom layers emit light in the same or similar color region while the middle layer emits light in a different color region than the other two layers. In such an embodiment, the three layers are in contact with each other with no other layers in between. The symmetric emissive-layer architecture of the present invention can be used to improve the color stability of OLED devices.
Embodiments of the disclosed subject matter provide a device that includes a full color display. A camera may be disposed below the full color display. A controller may modify a video signal applied to one or more sub-pixels of the full color display based on a predicted degradation of the one or more sub-pixels, such that the modification is updated by the controller based on luminance data for the one or more subpixels acquired by the camera.
G09G 3/20 - Control arrangements or circuits, of interest only in connection with visual indicators other than cathode-ray tubes for presentation of an assembly of a number of characters, e.g. a page, by composing the assembly by combination of individual elements arranged in a matrix
G09G 3/3208 - Control arrangements or circuits, of interest only in connection with visual indicators other than cathode-ray tubes for presentation of an assembly of a number of characters, e.g. a page, by composing the assembly by combination of individual elements arranged in a matrix using controlled light sources using electroluminescent panels semiconductive, e.g. using light-emitting diodes [LED] organic, e.g. using organic light-emitting diodes [OLED]
Provided are organometallic compounds comprising at least one central metal atom which is selected from palladium or platinum, the central metal atom being coordinated by at least one first ligand comprising at least two 6-membered aromatic rings which are fused together. Also provided are formulations comprising these organometallic compounds. Further provided are compositions, organic light emitting devices (OLEDs) as well as related consumer products that utilize these organometallic compounds.
Provided are organometallic compounds having a structure of Formula I:
Provided are organometallic compounds having a structure of Formula I:
Provided are organometallic compounds having a structure of Formula I:
Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.
Embodiments of the disclosed subject matter provide a plurality of pixels, where each pixel of the plurality of pixels may have three or more sub-pixels, and where a first sub-pixel of the three or more sub-pixels of a first pixel of the plurality of pixels emits a first color light. A controller may be communicatively coupled to the plurality of pixels. The controller may be configured to receive an input signal that specifies a luminance for the first sub-pixel and a group of sub-pixels that emit the first color light in N pixels, where the N pixels comprise the first pixel and at least one pixel adjacent to the first pixel, and output an output signal to drive the first sub-pixel at a luminance equal to a sum of luminance values specified in the input signal for the group of sub-pixels that emit the first color light in the N pixels.
G09G 3/20 - Control arrangements or circuits, of interest only in connection with visual indicators other than cathode-ray tubes for presentation of an assembly of a number of characters, e.g. a page, by composing the assembly by combination of individual elements arranged in a matrix
G09G 3/3208 - Control arrangements or circuits, of interest only in connection with visual indicators other than cathode-ray tubes for presentation of an assembly of a number of characters, e.g. a page, by composing the assembly by combination of individual elements arranged in a matrix using controlled light sources using electroluminescent panels semiconductive, e.g. using light-emitting diodes [LED] organic, e.g. using organic light-emitting diodes [OLED]
Provided are organometallic compounds comprising a platinum or palladium atom as the central metal atom which is coordinated by an at least tetradentate ligand. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) as well as related consumer products that utilize these organometallic compounds.
Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.
A compound having a Formula of Ir(LA)x(LB)y(LC)z, where each of x and y is independently 1 or 2, z is 0 or 1 or 2, and x+y+z=3. In Formula Ir(LA)x(LB)y(LC)z, LA includes a structure of Formula I,
A compound having a Formula of Ir(LA)x(LB)y(LC)z, where each of x and y is independently 1 or 2, z is 0 or 1 or 2, and x+y+z=3. In Formula Ir(LA)x(LB)y(LC)z, LA includes a structure of Formula I,
A compound having a Formula of Ir(LA)x(LB)y(LC)z, where each of x and y is independently 1 or 2, z is 0 or 1 or 2, and x+y+z=3. In Formula Ir(LA)x(LB)y(LC)z, LA includes a structure of Formula I,
LB includes a structure of Formula II,
A compound having a Formula of Ir(LA)x(LB)y(LC)z, where each of x and y is independently 1 or 2, z is 0 or 1 or 2, and x+y+z=3. In Formula Ir(LA)x(LB)y(LC)z, LA includes a structure of Formula I,
LB includes a structure of Formula II,
A compound having a Formula of Ir(LA)x(LB)y(LC)z, where each of x and y is independently 1 or 2, z is 0 or 1 or 2, and x+y+z=3. In Formula Ir(LA)x(LB)y(LC)z, LA includes a structure of Formula I,
LB includes a structure of Formula II,
LC is a bidentate ligand; each of X1 to X25 is C or N; Y is a linking group; Lo is a direct bond or a linking group; L is a direct bond or an organic linker; each of moieties A, D, and F is a monocyclic ring or a polycyclic fused ring system; and each substituent is independently H or a General Substituent defined herein. Formulations, OLEDs, and consumer products containing the compound are also provided.
H10K 50/125 - OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers specially adapted for multicolour light emission, e.g. for emitting white light
C07F 15/00 - Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
Provided are organometallic compounds having Formula I:
Provided are organometallic compounds having Formula I:
Provided are organometallic compounds having Formula I:
Also provided are formulations including these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.
Organic electroluminescent devices are provided, including devices having an emissive layer in addition to an outcoupling layer with material having an emissive state. The material having an emissive state within the outcoupling layer converts the energy confined in the multipolar localized surface plasmon resonance modes to dipolar emissive modes, thereby increasing the light outcoupling efficiency of devices.
Organic emissive devices are provided that include host structures with electron and/or hole transporting components having specific energy levels that promote good charge balance and enhanced charge capture. The disclosed energy level structures provide host systems that reduce exciplex formation and thereby promote improved device internal quantum efficiency and stability, or which intentionally include exciplex formation so as to modify the average orientation of the dipole.
A compound having a first ligand LA of Formula I
A compound having a first ligand LA of Formula I
A compound having a first ligand LA of Formula I
is provided. In Formula I, two RA substituents are joined to form a ring A′, wherein A′ is a 5-membered ring that is fused to ring A, wherein A′ can be further fused or substituted by RA′ and two RC substituents are joined to form a ring C′, wherein C′ is a 5-membered ring that is fused to ring C, wherein C′ can be further fused or substituted by RC′. Compositions, OLEDs and consumer products containing the compound are also provided.
A compound of formula Ir(LA)x(LB)y(LC)z having a first ligand LA of Formula I
A compound of formula Ir(LA)x(LB)y(LC)z having a first ligand LA of Formula I
A compound of formula Ir(LA)x(LB)y(LC)z having a first ligand LA of Formula I
is provided. In Formula I, at least one RA, RB, or RC comprises a group R* having a structure of Formula II,
A compound of formula Ir(LA)x(LB)y(LC)z having a first ligand LA of Formula I
is provided. In Formula I, at least one RA, RB, or RC comprises a group R* having a structure of Formula II,
A compound of formula Ir(LA)x(LB)y(LC)z having a first ligand LA of Formula I
is provided. In Formula I, at least one RA, RB, or RC comprises a group R* having a structure of Formula II,
wherein at least one of R1, R2, or R3 comprises an aryl or heteroaryl group. Compositions, OLEDs and consumer products containing the compound are also provided.
A compound having a first ligand LA comprising a structure of Formula I,
A compound having a first ligand LA comprising a structure of Formula I,
A compound having a first ligand LA comprising a structure of Formula I,
is provided, where: each of moiety A and moiety B is a monocyclic ring or a polycyclic fused ring system; each of X1 to X4 and Z1 and Z2 is C or N; K1 and K2 are each a direct bond or a linker; L1 is a direct bond or an organic linker; each Rα, Rβ, RA and RB is hydrogen or a General Substituent defined herein; and at least one RA or one RB comprises R*, where R* is an alkyl group, a silyl group, a germyl group, or a combination thereof. Formulations, OLEDs, and consumer products containing the compound are also provided.
A first device including a first organic light emitting device is provided. The first OLED includes an anode; a cathode; and a first emissive layer, disposed between the anode and the cathode, comprising a first emissive dopant that is a phosphorescent metal compound having an emission peak wavelength between 530 nm to 580 nm. The first device also includes a second emissive layer that includes a fluorescent compound, a phosphorescent compound, or both; and the first device is capable of emitting white light.
H05B 33/14 - Light sources with substantially two-dimensional radiating surfaces characterised by the chemical or physical composition or the arrangement of the electroluminescent material
H10K 50/11 - OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
H10K 85/60 - Organic compounds having low molecular weight
Novel compounds comprising heteroleptic iridium complexes are provided. The compounds have a particular combination of ligands which includes a single pyridyl dibenzo-substituted ligand. The compounds may be used in organic light emitting devices, particularly as emitting dopants, to provide devices having improved efficiency, lifetime, and manufacturing.
Organic electroluminescent devices are provided, including devices having a unique outcoupling design, wherein the outcoupling layer includes an array of nanoparticles. The array of nanoparticles is arranged in a quasiperiodic array. The quasiperiodic array of nanoparticles allows for more random spacing of the nanoparticles which enhance the device efficiency and allows for tunability of the emission profile by tuning the symmetry of the nanoparticle arrays within the outcoupling layer.
An organic electroluminescent device (OLED) comprising an anode; a cathode; and an emissive layer, disposed between the anode and the cathode is provided. The emissive layer comprises a phosphorescent dopant, a first host, and a second host, where the first host is a hole transporting host, the second host is an electron transporting host, the first host has a HOMO energy≤−5.45 eV and/or the first host comprises a structure of Formula V:
An organic electroluminescent device (OLED) comprising an anode; a cathode; and an emissive layer, disposed between the anode and the cathode is provided. The emissive layer comprises a phosphorescent dopant, a first host, and a second host, where the first host is a hole transporting host, the second host is an electron transporting host, the first host has a HOMO energy≤−5.45 eV and/or the first host comprises a structure of Formula V:
An organic electroluminescent device (OLED) comprising an anode; a cathode; and an emissive layer, disposed between the anode and the cathode is provided. The emissive layer comprises a phosphorescent dopant, a first host, and a second host, where the first host is a hole transporting host, the second host is an electron transporting host, the first host has a HOMO energy≤−5.45 eV and/or the first host comprises a structure of Formula V:
and the phosphorescent dopant has a formula Ir(LA)x(LB)y(LC)z. In formula Ir(LA)x(LB)y(LC)z, ligand LA has a structure of Formula I,
An organic electroluminescent device (OLED) comprising an anode; a cathode; and an emissive layer, disposed between the anode and the cathode is provided. The emissive layer comprises a phosphorescent dopant, a first host, and a second host, where the first host is a hole transporting host, the second host is an electron transporting host, the first host has a HOMO energy≤−5.45 eV and/or the first host comprises a structure of Formula V:
and the phosphorescent dopant has a formula Ir(LA)x(LB)y(LC)z. In formula Ir(LA)x(LB)y(LC)z, ligand LA has a structure of Formula I,
An organic electroluminescent device (OLED) comprising an anode; a cathode; and an emissive layer, disposed between the anode and the cathode is provided. The emissive layer comprises a phosphorescent dopant, a first host, and a second host, where the first host is a hole transporting host, the second host is an electron transporting host, the first host has a HOMO energy≤−5.45 eV and/or the first host comprises a structure of Formula V:
and the phosphorescent dopant has a formula Ir(LA)x(LB)y(LC)z. In formula Ir(LA)x(LB)y(LC)z, ligand LA has a structure of Formula I,
where: moiety A is a ring; moiety B is a fused ring structure comprising at least three rings; K is a direct bond or a linker; Z1 and Z2 are C or N; each RA and RB is hydrogen or a General Substituent defined herein. Consumer products containing the OLED are also provided.
Provided are organic compounds comprising a boron atom as the central atom which is bonded to three 6-membered aromatic carbocyclic or heterocyclic rings. Also provided are formulations comprising these organic compounds. Further provided are organic light emitting devices (OLEDs) as well as related consumer products that utilize these organic compounds.
A device is provided that includes a full color organic light emitting diode (OLED) having a plurality of pixels, where each pixel has a plurality of sub-pixels. A first pixel of the plurality of pixels may include a first sub-pixel having a top emission device or a bottom emission device, and a second sub-pixel comprises a first plasmonic stack. In some embodiments, a full color organic light emitting diode (OLED) may be provided having a plurality of pixels, where each pixel comprises a plurality of sub-pixels. At least one sub-pixel of the plurality of sub-pixels may be configured differently from the other sub-pixels by a different angular emission profile and/or a different cathode material or organic stack design.
Provided are organometallic compounds comprising as a central metal atom a platinum or palladium atom which is coordinated by a tetradentate ligand comprising at least two 5-10-membered rings which are coordinated to the central metal atom. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) as well as related consumer products that utilize these organometallic compounds.
Light emitting devices are provided that include an outcoupling layer in which asymmetric nanoparticles are disposed, where the nanoparticles are aligned such that the difference between each nanoparticle's major axis and the average direction of the major axes of all nanoparticles is minimized. The use of aligned, physically asymmetric nanoparticles leads to improved outcoupling and performance of the device.
H10K 50/115 - OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers comprising active inorganic nanostructures, e.g. luminescent quantum dots
H10K 71/10 - Deposition of organic active material
A compound having a first ligand LA of structure of Formula I,
A compound having a first ligand LA of structure of Formula I,
A compound having a first ligand LA of structure of Formula I,
is provided. In the structure, each of moiety A and moiety C is a monocyclic ring or a polycyclic fused ring system; moiety B is a polycyclic fused ring system including at least four fused rings; each of Z1 to Z3 is C or N; L is a direct bond or a linking group; K is a direct bond or a linking group; each R, R′, Rα, Rβ, RA, RB, and RC is hydrogen or a General Substituent defined herein; and LA is coordinated to a metal M. Formulations, OLEDs, and consumer products containing the compound are also provided.
A compound having a first ligand LA having a moiety R* comprising a structure of Formula I,
A compound having a first ligand LA having a moiety R* comprising a structure of Formula I,
A compound having a first ligand LA having a moiety R* comprising a structure of Formula I,
is provided. In Formula I, each of moiety A and moiety B is a monocyclic ring or a polycyclic fused ring structure; each of Y1, Y2, Y3, and Y4 is a single atom linker, each R, R′, RA and RB is hydrogen or a General Substituent defined herein; LA is a bidentate ligand coordinated to a metal M; and M is selected from Ir, Rh, Re, Ru, Os, Pt, Pd, Ag, Au, and Cu. Formulations, OLEDs, and consumer products containing the compound are also provided.
Embodiments of the disclosed subject matter provide a device that may include a substrate, a first electrode disposed over the substrate, and a first organic emissive layer (EML) disposed over the first electrode, with the first EML including a first emissive material. A second electrode may be disposed over the first EML. A first self-absorbing material (SAM) may be disposed in a stack with the substrate, where the SAM may include a material that transfers at least a portion of the energy from the first EML to the first SAM.
H10K 50/115 - OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers comprising active inorganic nanostructures, e.g. luminescent quantum dots
Provided are organometallic compounds comprising a platinum or palladium atom as the central metal atom which is coordinated by a tetradentate ligand comprising at least one imidazole ring which is fused to a 6-membered aromatic ring. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) as well as related consumer products that utilize these organometallic compounds.
Provided are organometallic compounds comprising a platinum atom or a palladium atom as the central metal atom which is coordinated by a tetradentate ligand comprising at least four aromatic 6-membered rings and at least one nitrogen-containing 5-membered ring. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.
Provided are organometallic compounds comprising a platinum atom as the central metal atom which is coordinated by two bidentate ligands which may be linked to comprise a tetradentate ligand. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) as well as related consumer products that utilize these organometallic compounds.
Provided are organometallic compounds comprising as the central metal atom a platinum or palladium atom which is coordinated by a tetradentate ligand comprising at least two 6-membered aromatic rings which are connected via an nitrogen atom. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.
A compound comprising a structure of Formula I,
A compound comprising a structure of Formula I,
A compound comprising a structure of Formula I,
is provided. In Formula I, each of moiety A and, when present, moiety D is a monocyclic ring or a polycyclic fused ring system; M is Pt or Pd; each of X1 to X10, Z1, and Z2 is C or N; each of L1 and L2 is a direct bond or a linking group; each of K1, K2, and K3 is a direct bond or a linking group; Y2 is a linking group; at least one pair of RC are joined or fused to form a 5-membered or 6-membered aromatic ring, which can be further fused or substituted; each R substituent is hydrogen or a General Substituent defined herein. Formulations, OLEDs, and consumer products containing the compound are also provided.
Provided are new compositions of matter for host materials in OLEDs by incorporating deuterated moieties in the organic molecules. Also provided are formulations comprising these deuterated compounds. Further provided are OLEDs and related consumer products that utilize these deuterated compounds.
C07D 519/00 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
C07F 7/08 - Compounds having one or more C—Si linkages
H10K 50/11 - OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
H10K 85/40 - Organosilicon compounds, e.g. TIPS pentacene
H10K 85/60 - Organic compounds having low molecular weight
A reconfigurable thin-film photonic filter weight bank comprises at least one photodetector and at least one optical filtering device comprising a pair of reflective thin film stacks with an interstitial medium cavity therebetween forming an optical cavity. Operation of a bank occurs when the reflective film is more selectively reflective to a range of frequencies and is more translucent to frequencies outside the range. The bank can reconfigurably weight signals by varying the cavity sizes or complex indices of refraction, with one photodetector integrating the weighted signals. Detectors can also be embedded inside the individual cavities to output unweighted, but demultiplexed, electrical signals. A neuromorphic opto-electronic system comprises a plurality of interconnected artificial optical neurons, each including at least one thin film neuromorphic opto-electronic device with a reconfigurable thin-film photonic filter weight bank. Related methods are also disclosed.
A compound having formula (LA)nIr(LB)3-n or formula (LA)mPt(LC)2-m is provided, in which the ligand LA has a structure of Formula I,
A compound having formula (LA)nIr(LB)3-n or formula (LA)mPt(LC)2-m is provided, in which the ligand LA has a structure of Formula I,
A compound having formula (LA)nIr(LB)3-n or formula (LA)mPt(LC)2-m is provided, in which the ligand LA has a structure of Formula I,
wherein R has the structure of
A compound having formula (LA)nIr(LB)3-n or formula (LA)mPt(LC)2-m is provided, in which the ligand LA has a structure of Formula I,
wherein R has the structure of
A compound having formula (LA)nIr(LB)3-n or formula (LA)mPt(LC)2-m is provided, in which the ligand LA has a structure of Formula I,
wherein R has the structure of
where two adjacent atoms from the four atoms marked with * are C and are fused to ring B. In Formulas I and II, ring A is a carbocyclic or heterocyclic ring; ring B is an aromatic ring; X is NR′, CR′R″, SiR′R″, O, S or Se; each of Z and X1 to X13 are carbon or nitrogen; R1, R2, R3, R4, R′, and R″ are each hydrogen or a substituent; LB is an unsubstituted or substituted phenyl pyridine bidentate ligand or its derivative; and LC is a bidentate ligand.
Provided are organometallic compounds comprising a platinum or palladium atom as a central metal atom which is coordinated by a tetradentate ligand comprising at least five 5- to 10-membered rings of which on is a 6-membered aromatic nitrogen-containing ring. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) as well as related consumer products that utilize these organometallic compounds.
The present disclosure provides for an organic electroluminescent device (OLED) including an anode; a cathode; and an emissive layer, disposed between the anode and the cathode. The emissive layer includes a phosphorescent dopant, a first host, and a second host, wherein the first host transports holes, the second host transports electrons, and the first host is fully or partially deuterated. Consumer products that include the OLED are also provided.
C07D 209/86 - CarbazolesHydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
H10K 50/11 - OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
Provided are organoiridium compounds. Also provided are formulations comprising these organoiridium compounds. Further provided are OLEDs and related consumer products that utilize these organoiridium compounds.
Cyclometallated iridium complexes having triphenylene or aza triphenylene and bulky alkyl substitution that can be used as emitters in OLEDs to improve the external quantum efficiency (EQE) and lifetime of OLEDs are disclosed.
Embodiments of the disclosed subject matter provide a method of coating a surface with an active pharmaceutical ingredient, where an organic source having a first organic material may be heated to create an organic vapor, the first organic material having an active pharmaceutical ingredient. The source vapor may be transported via an inert carrier gas to a confined organic printing COP depositor in a deposition chamber. The organic vapor entrained in the inert carrier gas may be ejected from the COP depositor toward a surface to cause the first organic material to condense on the surface.
A compound is provided that has a formula Ir(LA)x(LB)y(LC)z, where each of x and y is independently 1 or 2, z is 0 or 1, and x+y+z=3; ligand LA comprises a structure of Formula I,
A compound is provided that has a formula Ir(LA)x(LB)y(LC)z, where each of x and y is independently 1 or 2, z is 0 or 1, and x+y+z=3; ligand LA comprises a structure of Formula I,
A compound is provided that has a formula Ir(LA)x(LB)y(LC)z, where each of x and y is independently 1 or 2, z is 0 or 1, and x+y+z=3; ligand LA comprises a structure of Formula I,
ligand LB comprises a structure of Formula II,
A compound is provided that has a formula Ir(LA)x(LB)y(LC)z, where each of x and y is independently 1 or 2, z is 0 or 1, and x+y+z=3; ligand LA comprises a structure of Formula I,
ligand LB comprises a structure of Formula II,
A compound is provided that has a formula Ir(LA)x(LB)y(LC)z, where each of x and y is independently 1 or 2, z is 0 or 1, and x+y+z=3; ligand LA comprises a structure of Formula I,
ligand LB comprises a structure of Formula II,
and ligand LC is a bidentate ligand. In Formulas I and II, each of X1 to X14 is C or N; Y is a linking group; each R, R′, R*, R1, R2, R3, RA, RB, RC, and RE is a hydrogen or a variety of substituent defined herein; and R4 comprises a tertiary or secondary alkyl group and can also include one or more General Substituents defined herein. Formulations, OLEDs, and consumer products containing the compound are also provided.
A compound of formula Ir(LA)n(LB)m(LC)o having a ligand LA of Formula I
A compound of formula Ir(LA)n(LB)m(LC)o having a ligand LA of Formula I
A compound of formula Ir(LA)n(LB)m(LC)o having a ligand LA of Formula I
is provided. In Formula I, moiety A and moiety E are each independently a monocyclic ring or a polycyclic fused ring system, wherein the monocyclic ring or each ring of the polycyclic fused ring system is independently a 5-membered to 10-membered carbocyclic or heterocyclic ring. Moiety A is joined to ring D at X6, X7, or X8 and said X6, X7, or X8 to which moiety A joins is C. In Formula I, when Y is O, S, or CRR′, and moiety E is a 6-membered aromatic ring, then at least one pair of R1 or one pair of R2 are joined to form moiety I, wherein moiety I is a monocyclic ring or a polycyclic fused ring system, wherein the monocyclic ring or each ring of the polycyclic fused ring system is independently a 5-membered to 10-membered carbocyclic or heterocyclic ring. Formulations, OLEDs and consumer products containing the compound are also provided.
Embodiments of the disclosed subject matter provide a device including one or more organic layers that include an emissive layer, a first electrode layer disposed over the one or more organic layers, a plurality of nanostructures formed as part of the first electrode layer, a substrate, a second electrode layer, where the second electrode layer is disposed on the substrate, the one or more organic layers are disposed on the second electrode layer, and the first electrode layer including the plurality of nanostructures is disposed on the one or more organic layers and within the predetermined threshold distance of the emissive layer.
H10K 50/115 - OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers comprising active inorganic nanostructures, e.g. luminescent quantum dots
H10K 50/822 - Cathodes characterised by their shape
H10K 50/85 - Arrangements for extracting light from the devices
H10K 50/858 - Arrangements for extracting light from the devices comprising refractive means, e.g. lenses
A compound having a structure of Formula I
A compound having a structure of Formula I
A compound having a structure of Formula I
In Formula I, M is Pd or Pt; each of X1 to X12 is independently C or N; ring A is a 5-membered or 6-membered ring; K1 and K2 are selected from a direct bond, O, S, and NR; L1 is an organic linker; Y1 is selected from O, S, BR, PR, Se and NRY; each R, RY, RA, RB, RC, and RD is hydrogen or a substituent; and any two substituents can be joined or fused to form a ring. Further provided are OLEDs and related consumer products that utilize these compounds.
A compound having a first ligand LA comprising a structure of Formula I,
A compound having a first ligand LA comprising a structure of Formula I,
A compound having a first ligand LA comprising a structure of Formula I,
is provided. In Formula I, moiety B is a monocyclic ring or a polycyclic fused ring system; each of X1 to X6 is C or N; Y is a linking group; K is a direct bond or a linking group; each substituent is hydrogen or a General Substituent defined herein; and at least one of the following conditions is true: (1) an RA substituent is joined with an RB substituent to form a ring AB, which may be substituted by one or more RAB substituents; or (2) X5 and X6 are C, and the corresponding two RA substituents are joined to form a cyclic moiety A1, which may be substituted by one or more RA1 substituents; and moiety B is a polycyclic fused ring system. Formulations, OLEDs, and consumer products containing the compound are also provided.
Provided are organoboron compounds. Also provided are formulations comprising these organoboron compounds. Further provided are OLEDs and related consumer products that utilize these organoboron compounds.
A compound of Formula I,
A compound of Formula I,
A compound of Formula I,
is provided. In Formula I; ring A is a 5-membered or 6-membered aromatic ring; wherein Y1 is absent or a linking group; each of X1 to X3 is N or CR, and at least one of X1 to X3 is N; each of A1 to A5 is C or N; each R1, R2, R3, and R4 is independently selected from the group consisting of alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aryl, heteroaryl, and combinations thereof, and each R, R′, RA, RB, and RC is hydrogen or a General Substituent; and the compound is partially or fully deuterated.
H10K 85/60 - Organic compounds having low molecular weight
C07D 403/14 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings
A compound having a structure including
A compound having a structure including
A compound having a structure including
is provided. In these structures, M is Pt or Pd; each of X1 to X22 is N or CR; each of L1 and, where present, Y, is a direct bond or a linking group; each R substituent is a hydrogen atom or a General Substituent defined herein; RA is hydrogen or a General Substituent defined herein; and any two substituents may be joined or fused to form a ring. Formulations, OLEDs, and consumer products containing the compound are also disclosed.
A compound comprising a ligand LA of Formula I,
A compound comprising a ligand LA of Formula I,
A compound comprising a ligand LA of Formula I,
where G has a structure of
A compound comprising a ligand LA of Formula I,
where G has a structure of
A compound comprising a ligand LA of Formula I,
where G has a structure of
is disclosed. In ligand LA, Ring C is a 5-membered or 6-membered ring; K is a direct bond, O, or S; when K is O or S, X6 is C; each of RA, RB, and RC is H or a substituent, and can be joined together to form a ring; each of X1 to X6 is independently C or N; X1 is C if it is connected to ring C; the RB substituents of at least two adjacent ones of X2 to X5 are joined to form a ring; and the ligand LA is complexed to Ir through the two indicated dash lines to form a 5-membered chelate ring. Organic light emitting devices, consumer products, formulations, and chemical structures containing the compounds are also disclosed.
Provided are compounds having the structure of Formula I:
Provided are compounds having the structure of Formula I:
Provided are compounds having the structure of Formula I:
wherein rings A, B, and D are each independently a 5-membered or 6-membered carbocyclic or heterocyclic ring; X1—X9 are each independently C or N; Y1 is selected from the group consisting of a direct bond, O, S, Se, NR, SiRR′, CRR′, and P(O)R; R, R′, RA, RB, RC, and RD each independently represents mono to the maximum allowable substitution, or no substitution; each R, R′, RA, RB, RC, and RD is independently a hydrogen or a substituent; and any two adjacent groups of RA, RB, RC, and RD may be joined or fused to form a ring Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.
Provided are organometallic compounds comprising a central metal atom which is coordinated by an at least two-dentate ligand comprising at least two rings A and B which are connected by a direct bond as well as a further linking group so that a 7-10 membered ring to which rings A and B are fused is formed. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) as well as related consumer products that utilize these organometallic compounds.
A compound having a structure of Formula I,
A compound having a structure of Formula I,
A compound having a structure of Formula I,
is provided. In Formula I, moiety A is a monocyclic ring or a polycyclic fused ring system; M is Pt or Pd; each of X1 to X18, T1 to T4, Z1, and Z2 is C or N; C* is a carbene carbon; each of A1 and A2 is a linking atom; Y1 is a linking atom; each of L1 and L2 is a direct bond or a linking atom; each of K1 to K4 is a direct bond or a linking atom; and each R is hydrogen or a General Substituent defined herein. Formulations, OLEDs, and consumer products containing the compound are also provided.
A compound comprising a structure of Formula I,
A compound comprising a structure of Formula I,
A compound comprising a structure of Formula I,
is provided. In Formula I, moiety A is a monocyclic ring or a polycyclic fused ring system; M is Pt or Pd; each of X1 to X13, Z1, and Z2 is C or N; Y1 is C, N, O, S, Se, P, and As; each of A1 and A2 is C, Si, N, B, P, and As; L1 and L2 are a direct bond or a linker; each of K1, K2, K3, and K4 is a direct bond or a linking group; each R substituent is hydrogen or a General Substituent defined herein; R* is a General Substituent defined herein; and at least one of X1 to X4 is N and at least one of RA, RB, RC, or RD is not H. Formulations, OLEDs, and consumer products containing the compound are also provided.
An OLED is provided that includes an anode; a cathode; and an emissive region, disposed between the anode and the cathode. The emissive region includes a first compound (S1), a second compound (A1), and a host, wherein the first compound is capable of phosphorescent emission in the range from 540 nm to 750 nm; and the second compound is capable of fluorescent or delayed fluorescent emission in the range from 580 nm to 750 nm. The first compound has the formula M(LA)x(LB)y(LC)z, where first ligand LA includes a structure of Formula I,
An OLED is provided that includes an anode; a cathode; and an emissive region, disposed between the anode and the cathode. The emissive region includes a first compound (S1), a second compound (A1), and a host, wherein the first compound is capable of phosphorescent emission in the range from 540 nm to 750 nm; and the second compound is capable of fluorescent or delayed fluorescent emission in the range from 580 nm to 750 nm. The first compound has the formula M(LA)x(LB)y(LC)z, where first ligand LA includes a structure of Formula I,
An OLED is provided that includes an anode; a cathode; and an emissive region, disposed between the anode and the cathode. The emissive region includes a first compound (S1), a second compound (A1), and a host, wherein the first compound is capable of phosphorescent emission in the range from 540 nm to 750 nm; and the second compound is capable of fluorescent or delayed fluorescent emission in the range from 580 nm to 750 nm. The first compound has the formula M(LA)x(LB)y(LC)z, where first ligand LA includes a structure of Formula I,
where each of moiety A and B is a monocyclic ring or a polycyclic fused ring system; Z1 to Z4 are C or N; each of L and K is a direct bond or a linker; and the substituents are hydrogen or a General Substituent defined herein. Consumer products containing the OLED are also provided.
Provided is an organic light emitting device (OLED) comprising: an anode; a cathode; and an emissive region disposed between the anode and the cathode; wherein the emissive region comprises: a compound S1; a compound A1; and a compound H1; wherein the compound S1 is a sensitizer that transfers energy to the compound A1; wherein the compound A1 is an acceptor that is an emitter, and wherein the compound H1 is a host. Also provided are the devices containing an OLED as described herein. Further provided are compositions and methods of deuterating aromatic compounds and for making these OLEDs.
Embodiments of the disclosed subject matter provide a device having at least one pixel comprising three or more sub-pixels. Each sub-pixel may include an organic emissive layer having an organic emissive material, and an enhancement layer having a plasmonic material that is more than a threshold distance away from the organic emissive layer. Each sub-pixel may include an outcoupling layer disposed over the enhancement layer and a color altering layer disposed over the outcoupling layer, where there is an overlap between a transmission spectrum of the color altering layer and an emission spectrum of light output from the outcoupling layer. For at least one sub-pixel of the three or more sub-pixels, a full width half maximum (FWHM) of a light emission spectrum from the color altering layer may be between 30 nm greater than or 30 nm less than the FWHM of a light emission spectrum from the outcoupling layer.
Organic electroluminescent devices are provided, including devices having an outcoupling layer with shaped structures. The shaped structures can induce strong field confinement in the outcoupling layer to enhance the Purcell values at different wavelengths. The shape and/or dimensions of the shaped structures can be selected to tune the devices for particular wavelengths.
A compound having a first ligand LA including a structure of Formula I,
A compound having a first ligand LA including a structure of Formula I,
A compound having a first ligand LA including a structure of Formula I,
is provided. In Formula I, each of X1 to X6 is independently C or N; X and Y are selected from a group of linking atoms; K is a direct bond or a linking atom; each R is hydrogen or a General Substituent defined therein; and LA is coordinated to a metal M, having an atomic mass of at least 40. Formulations, OLEDs, and consumer products containing the compound are also provided.
A compound having a first ligand LA comprising a structure of Formula I
A compound having a first ligand LA comprising a structure of Formula I
A compound having a first ligand LA comprising a structure of Formula I
is provided. In the compound, two RA are joined to form a cyclic moiety A1, which may be substituted by RA1; each of moieties A1 and C is a monocyclic ring or a polycyclic fused ring system; each of X1 to X6 is C or N; K is a direct bond or a linking group; Y is a linking group; each substituent is hydrogen or a General Substituent; LA is coordinated to a metal M. Formulations, OLEDs, and consumer products containing the compound are also provided.
A metal iridium complexes, devices containing the same, and formulations including the same described. The complexes can have the formula Ir(L1)n(L2)3−n, wherein
the first ligand L1 has Formula I,
A metal iridium complexes, devices containing the same, and formulations including the same described. The complexes can have the formula Ir(L1)n(L2)3−n, wherein
the first ligand L1 has Formula I,
the second ligand L2 has Formula II,
A metal iridium complexes, devices containing the same, and formulations including the same described. The complexes can have the formula Ir(L1)n(L2)3−n, wherein
the first ligand L1 has Formula I,
the second ligand L2 has Formula II,
L1 is different from L2; R1 is a partially or fully deuterated group consisting of alkyl and cycloalkyl; R2 represents mono, di, tri substitutions or no substitution; R3, R4, and R5 each represent mono, di, tri, tetra substitutions or no substitution; R2 and R3 are each independently selected from the group consisting of hydrogen, deuterium, alkyl, cycloalkyl, and combinations thereof; R4 and R5 are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and n is 1 or 2. Homoleptic, tris-iridium complex including deuterated alkyl groups are also described.
A compound having a first ligand LA comprising a structure of Formula I,
A compound having a first ligand LA comprising a structure of Formula I,
A compound having a first ligand LA comprising a structure of Formula I,
is provided. In Formula I, moiety A is a monocyclic ring or a polycyclic fused ring system; Z1 and Z2 are C or N; each of Y1, Y2, Y3, A1 and A2 is a single atom linkage; K is a direct bond or a linking group; C1 is a carbon or a carbene carbon; L is a direct bond or a linking group; each substituent is hydrogen or a General Substituent defined herein; and first ligand LA is coordinated to a metal M through the two dashed lines. Formulations, OLEDs, and consumer products containing the compound are also provided.
A compound having a first ligand LA having a structure of Formula I
A compound having a first ligand LA having a structure of Formula I
A compound having a first ligand LA having a structure of Formula I
is provided. In Formula I, one of the following two statements is true: exactly one of X5 to X8 is N and two R3 are joined to form a benzene ring fused to ring C; or moiety A is pyridine, each of X5 to X8 is C, and two R3 are joined to form a pyridine ring fused to ring C. Compositions, OLEDs and consumer products containing the compound are also provided.
A compound comprising a metal M and a first ligand LA having a structure of Formula I,
A compound comprising a metal M and a first ligand LA having a structure of Formula I,
A compound comprising a metal M and a first ligand LA having a structure of Formula I,
is described. In Formula I, each independently represents a single bond or a double bond; each of X1′ to X4′ is independently C, N, or NR′; at least one of X1 to X4 is NR′; each RA′, R′, R1, R2, and R3 is independently hydrogen or a general substituent; at least one of RA′, R′, R1, R2, and R3 comprises the metal M; when X1 and X2 are both NR′, the B atom of Formula I forms a maximum of one direct bond to a nitrogen atom, and does not form a direct bond to an oxygen atom; and any two adjacent RA, R′, R1, R2, and R3 can be joined or fused to form a ring. Formulations, OLEDs, and consumer products including the compounds are also described.
Provided are organometallic compounds comprising a central metal atom and an at least two dentate ligand comprising at least three 6-membered aromatic rings which are fused together. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) as well as related consumer products that utilize these organometallic compounds.
A compound of Formula Ir(LA)x(LB)y(LC)z is provided where x and y are independently 1 or 2; z is 0 or 1; and x+y+z=3; first ligand LA includes a structure of Formula I,
A compound of Formula Ir(LA)x(LB)y(LC)z is provided where x and y are independently 1 or 2; z is 0 or 1; and x+y+z=3; first ligand LA includes a structure of Formula I,
A compound of Formula Ir(LA)x(LB)y(LC)z is provided where x and y are independently 1 or 2; z is 0 or 1; and x+y+z=3; first ligand LA includes a structure of Formula I,
ligand LB includes a structure of Formula II:
A compound of Formula Ir(LA)x(LB)y(LC)z is provided where x and y are independently 1 or 2; z is 0 or 1; and x+y+z=3; first ligand LA includes a structure of Formula I,
ligand LB includes a structure of Formula II:
A compound of Formula Ir(LA)x(LB)y(LC)z is provided where x and y are independently 1 or 2; z is 0 or 1; and x+y+z=3; first ligand LA includes a structure of Formula I,
ligand LB includes a structure of Formula II:
and ligand LC is a bidentate ligand. In the compounds, moiety B is a polycyclic fused ring system comprising at least four rings; each of moiety C and moiety D is a monocyclic ring or a polycyclic fused ring system; each of X1 to X4 and Z1 to Z6 is C or N; L0 is a direct bond or a linking group; YA is a linking group; each substituent is hydrogen or a General Substituent defined herein; and any two substituents may be joined or fused to form a ring. Formulations, OLEDs, and consumer products containing the compound are also provided.
A compound having a first ligand LA wherein the first ligand LA comprises a structure of Formula I
A compound having a first ligand LA wherein the first ligand LA comprises a structure of Formula I
A compound having a first ligand LA wherein the first ligand LA comprises a structure of Formula I
is provided. In Formula I, if R2 and R3 are not joined to form a ring, then at least two of R1 to R6 are not H. Also in Formula I, if R1 and R2 are not H, then R1 and R2 are also not bonded to the first ligand LA. Formulations, OLEDs and consumer products containing the compound are also provided.
A compound comprising a metal M and a ligand LA, where LA includes a structure of Formula I,
A compound comprising a metal M and a ligand LA, where LA includes a structure of Formula I,
A compound comprising a metal M and a ligand LA, where LA includes a structure of Formula I,
is disclosed. In Formula I, each of L1 and L2 is a direct bond of a linking group; each of X1 to X16 is C or N; each of R, R′, RA, RB, RC, and RD is independently hydrogen or a General Substituent. OLEDs, consumer products, and formulations including the compound are also disclosed.
A compound including a first ligand LA of Formula I,
A compound including a first ligand LA of Formula I,
A compound including a first ligand LA of Formula I,
is provided. In Formula I, moiety B is a fused polycyclic ring system; X1 to X4 are each C or N; K is a direct bond or a linker; LA is coordinated to a metal. Formulations, OLEDs, and consumer products containing such compounds are also provided.
Provided are organometallic compounds comprising a central metal atom which is coordinated by at least one ligand which is at least two-dentate and which comprises at least two 5-membered to 10-membered carbocyclic or heterocyclic rings. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.
A deposition device including an injection block and a print die is provided, which allows for vertical movement of the injection block while still maintaining connection between the print die and external gas sources. Also disclosed is an injection block suitable for such devices, which provides improved vertical range of motion and thermal consistency compared to conventional injection block devices.
A compound including a first ligand LA of Formula I,
A compound including a first ligand LA of Formula I,
A compound including a first ligand LA of Formula I,
is provided. In Formula I, moiety A is a monocyclic ring or a polycyclic fused ring system; moiety B is a polycyclic fused ring system having at least three rings; each of Z1 to Z4 is C or N; K is a direct bond or a linking group; each R substituent is hydrogen or a General Substituent defined herein; at least one RA includes a non-aromatic polycyclic group; LA is coordinated to a metal M; Z1 forms a dative bond with M; and Z2 forms an anionic bond to K. Formulations, OLEDs, and consumer products containing the compound are also provided.
A compound having a first ligand LA of Formula I
A compound having a first ligand LA of Formula I
A compound having a first ligand LA of Formula I
is provided. In Formula I, moiety A is a polycyclic fused ring system, wherein each ring of the polycyclic fused ring system is independently a 5-membered to 10-membered carbocyclic or heterocyclic ring and at least one of the following is true: (i) RA comprises a non-aromatic heterocyclic ring AH, or (ii) two RA are joined to form a non-aromatic heterocyclic ring A′ fused to moiety A, wherein the non-aromatic heterocyclic ring comprises at least one O, S, or N ring atom. Formulations, OLEDs and consumer products containing the compound are also provided.
Devices for deposition of material via organic vapor jet printing (OVJP) and similar techniques are provided. The depositor includes delivery channels ending in delivery apertures, where the delivery channels are flared as they approach the delivery apertures, and/or have a trapezoidal shape. The depositors are suitable for fabricating OLEDs and OLED components and similar devices.
H10K 71/13 - Deposition of organic active material using liquid deposition, e.g. spin coating using printing techniques, e.g. ink-jet printing or screen printing
C23C 16/44 - Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating
C23C 16/455 - Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating characterised by the method used for introducing gases into the reaction chamber or for modifying gas flows in the reaction chamber
Provided are organometallic compounds comprising a central metal atom and a ligand comprising at least four rings which are fused together, wherein at least one ring is a 6-membered aromatic ring. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.
A compound having a first ligand LA comprising a structure of Formula I,
A compound having a first ligand LA comprising a structure of Formula I,
A compound having a first ligand LA comprising a structure of Formula I,
is provided. In the compound, each of moiety A and moiety B is a monocyclic ring or a polycyclic fused ring system; at least one RA or RB has a structure of Formula II,
A compound having a first ligand LA comprising a structure of Formula I,
is provided. In the compound, each of moiety A and moiety B is a monocyclic ring or a polycyclic fused ring system; at least one RA or RB has a structure of Formula II,
A compound having a first ligand LA comprising a structure of Formula I,
is provided. In the compound, each of moiety A and moiety B is a monocyclic ring or a polycyclic fused ring system; at least one RA or RB has a structure of Formula II,
wherein the dashed line represents a bond to moiety A or moiety B, respectively; moiety D is a polycyclic fused ring system; each of Z1 to Z4 and X1 to X5 is C or N; L is a direct bond or a linking group; Y is a linking group; each of K1 and K2 is a direct bond or a linking group; and the dashed lines of Formula I are coordinated to a metal M. Formulations, OLEDs, and consumer products containing the compound are also provided.
Provided is a compound including a metal complex having a metal M with a coordination number of four with four coordinating atoms, Z1, Z2, Z3, and Z4, coordinated to the metal M. In the compound, each of Z1, Z2, Z3, and Z4 is independently selected from O, S, Se, N, P, C, Si, or B; at least one of Z1, Z2, Z3, or Z4 is S* or Se*, where S* and Se* represent S or Se, respectively, that form a dative bond with M; and the metal M is selected from Pt, Pd, Cu, Ag, Au, or Zn, Formulations, OLEDs, and consumer products containing the compound are also provided.
A compound having a first ligand LA comprising a structure of Formula I,
A compound having a first ligand LA comprising a structure of Formula I,
A compound having a first ligand LA comprising a structure of Formula I,
is provided. In Formula I, each of X1 to X14 is C or N; Z1 and Z2 are linking groups; Z3 is a direct bond or a linking group; K is a direct bond or a linking group; each R substituent is hydrogen or s General Substituent defined herein; LA is coordinated to a metal M; metal M may be coordinated to other ligands; and LA may be joined with other ligands. Formulations, OLEDs, and consumer products containing the compound are also provided.
Provided are organometallic compounds comprising a central metal atom and a ligand comprising an imidazole which fused to a monocyclic ring or a polycyclic fused ring system, wherein the monocyclic ring or each ring of the polycyclic fused ring system is independently a 5-membered to 10-membered carbocyclic or heterocyclic ring. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.
A compound of Formula Ir(LA)x(LB)y(LC)z is provided, where LA comprises a structure of Formula I,
A compound of Formula Ir(LA)x(LB)y(LC)z is provided, where LA comprises a structure of Formula I,
A compound of Formula Ir(LA)x(LB)y(LC)z is provided, where LA comprises a structure of Formula I,
and each of LB and LC is a bidentate ligand. In the compound, moiety A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; moiety B is a polycyclic fused ring system containing at least five rings; at least one RA comprises a structure of Formula II,
A compound of Formula Ir(LA)x(LB)y(LC)z is provided, where LA comprises a structure of Formula I,
and each of LB and LC is a bidentate ligand. In the compound, moiety A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; moiety B is a polycyclic fused ring system containing at least five rings; at least one RA comprises a structure of Formula II,
A compound of Formula Ir(LA)x(LB)y(LC)z is provided, where LA comprises a structure of Formula I,
and each of LB and LC is a bidentate ligand. In the compound, moiety A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; moiety B is a polycyclic fused ring system containing at least five rings; at least one RA comprises a structure of Formula II,
each of X1 to X5, Z1 and Z2 is C or N; K is a direct bond or a linker, Y is a linking group; L is a direct bond or a linking group; and each R substituent is hydrogen or a General Substituent defined herein. Formulations, OLEDs, and consumer products containing the same are also provided.
Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.
An organic light emitting device (OLED) is provided that includes an anode; a cathode; and an emissive region, disposed between the anode and the cathode. The emissive region comprises a compound A1 and an organometallic complex S1, wherein compound A1 is a coordination compound comprising a lanthanide metal. Consumer products containing the OLED are also provided.
Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.
A compound comprising a first ligand LA comprising a structure of Formula I,
A compound comprising a first ligand LA comprising a structure of Formula I,
is provided. In Formula I, moieties A, B, C, and D are each independently a monocyclic ring or a multicyclic fused ring system; each of X1 to X8 is C or N; each independently represents a single bond or a double bond; each of L1, L2, L3, and L4 is independently a direct bond or a linking group; each R, R′, R″, RA, RB, RC, and RD is a hydrogen or a General Substituent; any two adjacent R, R′, R″, RA, RB, RC, and RD may be joined or fused to form a ring; and LA is coordinated to a transition metal M. Formulations, OLEDs, and consumer products containing the compound are also provided.
A compound is disclosed that has a metal coordination complex structure having at least two ligands coordinated to the metal; wherein the compound has a first substituent R1 at one of the ligands' periphery; wherein a first distance is defined as the distance between the metal and one of the atoms in R1 where that atom is the farthest away from the metal among the atoms in R1; wherein the first distance is also longer than any other atom-to-metal distance between the metal and any other atoms in the compound; and wherein when a sphere having a radius r is defined whose center is at the metal and the radius r is the smallest radius that will allow the sphere to enclose all atoms in the compound that are not part of R1, the first distance is longer than the radius r by at least 2.9 A.
A compound (LA)M(LB) including a structure of Formula I,
A compound (LA)M(LB) including a structure of Formula I,
A compound (LA)M(LB) including a structure of Formula I,
and at least one structure of Formula II,
A compound (LA)M(LB) including a structure of Formula I,
and at least one structure of Formula II,
A compound (LA)M(LB) including a structure of Formula I,
and at least one structure of Formula II,
In the compound, each of moiety A and moiety B is a monocyclic ring or a polycyclic fused ring system; each of Z1, Z2, and X1 to X11 is independently C or N; at least one of X4 to X11 is N; Y is O, S, or Se; Y1, A1, and A2 is single atom linkers; each of L1 and L2 is a direct bond or a linker; M is Pt or Pd; each of K, K1 to K3 is a direct bond or a linker; and each R substituent is hydrogen or a General Substituent defined herein; and any two substituents may be fused or joined to form a ring. Formulations, OLEDs, and consumer products containing the compound are also provided.
A compound (LA)M(LB) having a structure of Formula I
A compound (LA)M(LB) having a structure of Formula I
A compound (LA)M(LB) having a structure of Formula I
is provided. In Formula I, each of moiety A and moiety B is a monocyclic ring or a polycyclic fused ring system, moiety B is a polycyclic fused ring system and subject to the provisos that: i) if each RC is H, one of X1, X4, and X7 is N, and the remaining ones of X1 to X8 are C, then at least one RD attached to X5 to X7 is not H; or ii) if each of X1 to X8 is C, then at least one of the following is true: (1) at least one RD attached to X5 or X7 is not H, or (2) at least one RC is not H. Formulations, OLEDs and consumer products containing the compound are also provided.
H10K 50/13 - OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers specially adapted for multicolour light emission, e.g. for emitting white light comprising stacked EL layers within one EL unit
C07F 15/00 - Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
A compound having a first ligand LA with a structure of Formula I,
A compound having a first ligand LA with a structure of Formula I,
A compound having a first ligand LA with a structure of Formula I,
where two consecutive ones of X1 to X8 are C and are joined to a structure of Formula II,
A compound having a first ligand LA with a structure of Formula I,
where two consecutive ones of X1 to X8 are C and are joined to a structure of Formula II,
A compound having a first ligand LA with a structure of Formula I,
where two consecutive ones of X1 to X8 are C and are joined to a structure of Formula II,
is provided. In Formula I, moiety A is a monocyclic ring or a polycyclic fused ring system; each of Z1 to Z2 and X1 to X12 is C or N; each of Y1 and Y2 is a linker; K is a direct bond or a linker; each substituent is hydrogen or a General Substituent defined herein; and LA is coordinated to a metal M. Also provided is a compound having a formula Ir(LA*)x(LB*)y(LC*)z as defined herein. Formulations, OLEDs, and consumer products containing these compounds are further provided.
Provided are organometallic compounds based on platin or palladium and their various uses including as emitters in devices having the structure of Formula I comprising at least four rings as defined herein. Also provided are formulations comprising these compounds. Further provided are organic light emitting devices and related consumer products that utilize these compounds.
Provided are compounds having a ligand LA of Formula I,
Provided are compounds having a ligand LA of Formula I,
Provided are compounds having a ligand LA of Formula I,
Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.
A compound having the formula Ir(LA)n(LB)3-m, having the structure
A compound having the formula Ir(LA)n(LB)3-m, having the structure
A compound having the formula Ir(LA)n(LB)3-m, having the structure
of Formula I is provided. In the structure of Formula I, each of A1 through A8 is independently carbon or nitrogen; at least one of A1 through A8 is nitrogen; ring B is bonded to ring A through a C—C bond; the iridium is bonded to ring A through an Ir—C bond; X is O, S, or Se; each of R1 through R5 are independently selected from a variety of substituents, which may be linked for form a ring; n is an integer from 1 to 3; and at least one R2 adjacent to ring C is not hydrogen. Formulations and devices, such as OLEDs, that include the first compound are also provided.
A compound having a first ligand LA of Formula I
A compound having a first ligand LA of Formula I
A compound having a first ligand LA of Formula I
is provided. In Formula I, moiety A and moiety D are each independently a monocyclic ring or fused polycyclic ring system, wherein the monocyclic ring or each ring of the polycyclic fused ring system is independently a 5-membered to 10-membered carbocyclic or heterocyclic ring. Moiety C is a 5-membered or 6-membered carbocyclic or heterocyclic ring. At least one RC or RD is a substituent R* comprising a carbocyclic or heterocyclic group. Formulations, OLEDs and consumer products containing the compound are also provided.
New organometallic complexes having bis- or tris- heteroleptic ligands and large aspect ratio in one direction and their use in OLEDs to enhance the efficiency is disclosed. Such compounds can have a structure of Formula III,
New organometallic complexes having bis- or tris- heteroleptic ligands and large aspect ratio in one direction and their use in OLEDs to enhance the efficiency is disclosed. Such compounds can have a structure of Formula III,
New organometallic complexes having bis- or tris- heteroleptic ligands and large aspect ratio in one direction and their use in OLEDs to enhance the efficiency is disclosed. Such compounds can have a structure of Formula III,
where rings A, B, C, and D are ring; L1 and L3 each a direct bond or a linking group; n1 and n2 are 0 or 1; if n1 or n2 is 1, then L2 or L4 is a direct bond or a linking group, and if n1 or n2 is 0, L2 or L4 is not present; Q1, Q2, Q3 and Q4 are a direct bond or oxygen; ring A is trans to ring D, ring B is trans to ring C in a square-planar coordination configuration; M2 is Pt, and the compound comprises at least one Pt-carbene bond.
